Доступ предоставлен для: Guest
Портал Begell Электронная Бибилиотека e-Книги Журналы Справочники и Сборники статей Коллекции
Journal of Environmental Pathology, Toxicology and Oncology
Импакт фактор: 1.625 5-летний Импакт фактор: 1.63 SJR: 0.402 SNIP: 0.613 CiteScore™: 2.3

ISSN Печать: 0731-8898
ISSN Онлайн: 2162-6537

Выпуски:
Том 40, 2021 Том 39, 2020 Том 38, 2019 Том 37, 2018 Том 36, 2017 Том 35, 2016 Том 34, 2015 Том 33, 2014 Том 32, 2013 Том 31, 2012 Том 30, 2011 Том 29, 2010 Том 28, 2009 Том 27, 2008 Том 26, 2007 Том 25, 2006 Том 24, 2005 Том 23, 2004 Том 22, 2003 Том 21, 2002 Том 20, 2001

Journal of Environmental Pathology, Toxicology and Oncology

DOI: 10.1615/JEnvironPatholToxicolOncol.2018028386
pages 51-59

Mitogen-Activated Protein Kinase (MAPK): New Insights in Breast Cancer

Huanyu Lu
Shandong University, Cheeloo College of Medicine, Jinan, Shandong Province, 250012, China
Yue Guo
Shandong University, Cheeloo College of Medicine, Jinan, Shandong Province, 250012, China
Gaurav Gupta
School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, 302017, Jaipur, India
Xingsong Tian
Shandong University, Cheeloo College of Medicine, Jinan, Shandong Province, 250012, China

Краткое описание

The eukaryotic cell cycle via mitogen-activated protein kinase (MAPK) has been considered as an effective signaling cascade pathway for anticancer therapy. In addition to the MAPK signaling pathway, the Rat Sarcoma Virus (Ras)/Rapidly Accelerated Fibrosarcoma (Raf)/MAPK–ERK kinase (MEK)/extracellular signal-regulated kinase (ERK) pathway is a signaling cascade that has a crucial role to play in cell survival and development of cancer, especially breast cancer. Novel drugs and clinical trials need to be investigated, taking into consideration the already studied genetic defects related to genesis of tumors in certain populations. The present review provides novel insights into current anticancer treatments involving the MAPK pathway.

Ключевые слова: MAPK, breast cancer, mortality, PI3K-AKT signaling

Articles with similar content:

RKIP-Mediated Chemo-Immunosensitization of Resistant Cancer Cells via Disruption of the NF-κB/Snail/YY1/RKIP Resistance-Driver Loop
Critical Reviews™ in Oncogenesis, Vol.19, 2014, issue 6
Benjamin Bonavida
Induction of RKIP Expression by Anticancer Therapeutic Antibodies and Its Role in the Reversal of Chemo- and Immunoresistance
Onco Therapeutics, Vol.2, 2011, issue 2
Benjamin Bonavida
Dual Role of p21 in the Progression of Cancer and Its Treatment
Critical Reviews™ in Eukaryotic Gene Expression, Vol.26, 2016, issue 1
Amna Parveen, Whang Wan Kyunn, Muhammad Sajid Hamid Akash, Kanwal Rehman
Dual Roles of Kruppel-Like Factor 4 as a Tumor Suppressor or Oncogene
Onco Therapeutics, Vol.7, 2016, issue 1-2
Peng-Sheng Zheng, Wen-Ting Yang
Overexpression of Yin Yang 1 in the Pathogenesis of Human Hematopoietic Malignancies
Critical Reviews™ in Oncogenesis, Vol.16, 2011, issue 3-4
Sara Huerta-Yepez, Mario I. Vega, H. Liu, Haiming Chen, Stavroula Baritaki, James R. Berenson, Benjamin Bonavida